Chronic dexamethasone exposure retards growth without altering the digestive tract microbiota composition in goats

Abstract

BackgroundDexamethasone (Dex), an artificially synthetic cortisol substitute, is commonly used as an anti-inflammatory drug, and is also employed to mimic the stress state experimentally. It is well known that chronic stress disturbs the gut microbiota community and digestive functions. However, no relevant studies have been conducted in ruminants.ResultsIn this study, a low dosage of Dex (0.2 mg/kg body weight, Dex group, n = 5) was consecutively injected intramuscularly for 21 days to simulate chronic stress in growing goats. Goats were injected with saline (0.2 mg/kg body weight) as the control group (Con, n = 5). Dex-treated goats showed a higher number of white blood cells and blood glucose levels (p < 0.01), but lower dry matter intake (DMI) and body weight (p < 0.01) than those of saline-injected goats. Plasma cortisol concentration decreased significantly in response to the Dex injection compared to the control (p < 0.05). The Dex treatment did not change most ruminal volatile fatty acid (VFAs) concentrations before the morning feeding after 1–21 days of treatment (p > 0.05); however, ruminal VFA concentrations decreased dramatically 2, 4, 6, and 8 h after the morning feeding on day 21 of the Dex injections. In this study, chronic Dex exposure did not alter the community structure of microbes or methanogenes in the rumen, caecum, or colonic digesta. Only Prevotella increased on days 7 and 14 of Dex treatment, but decreased on day 21, and Methanosphaera was the only genus of methanogene that decreased.ConclusionsOur results suggest that chronic Dex exposure retards growth by decreasing DMI, which may be mediated by higher levels of blood glucose and lower ruminal VFA production. Microbiota in the digestive tract was highly resistant to chronic Dex exposure.Electronic supplementary materialThe online version of this article (10.1186/s12866-018-1253-1) contains supplementary material, which is available to authorized users.

Predictors of Obesity among Gut Microbiota Biomarkers in African American Men with and without Diabetes

“…There have been no publications focused on examining the relationship between cortisol and gut microbiota in humans. In goats, chronic dexamethasone exposure increased gut Prevotella [62], while in cattle, stress associated with transportation resulted in an initial increase and subsequent decrease of blood cortisol and a similar initial increase and subsequent decline in gut Prevotella , suggesting congruent changes in cortisol and Prevotella [63]. Previously, Prevotella was linked to psychiatric disorders prevalent in our population, including depression [64] and substance use disorder [65], while no studies evaluated association with post-traumatic stress disorder (PTSD).…”

Potential roles of gut microbiota and microbial metabolites in chronic inflammatory pain and the mechanisms of therapy drugs

“…Dexamethasone is a synthetic substitute for cortisol, commonly used as an anti-inflammatory and also used to simulate stress state. 61 Dexamethasone can alleviate joint swelling and pain by improving the expression of inflammatory cytokines and transcription factors, such as IL-1β, IL-17, TNF-α, and MMP-3 in primary synovial tissue cells of CIA rats. Studies have shown that dexamethasone can downregulate the expression of the NF-κB signaling pathway in the serum of CIA rats, effectively treat knee OA, stabilize oxidative stress, and relieve pain.…”

Gut Microbiota Dysbiosis–Immune Hyperresponse–Inflammation Triad in Coronavirus Disease 2019 (COVID-19): Impact of Pharmacological and Nutraceutical Approaches

“…Finally, not all studies available show an effect of DEX in the GM. In a study performed with goats [ 107 ], chronic exposure to DEX did not change intestinal microbiota composition, suggesting that the GM was highly resistant to treatment with DEX.…”